Neuroradiology: Page 203

Infinitt releases new brain application
By AuntMinnie.com staff writers
RIS/PACS vendor Infinitt North America (formerly SmartPACS) of Phillipsburg, NJ, has launched its newest application, called Infinitt Brain Angio Subtraction.
May 30, 2007
256-slice CT brings new possibilities in head imaging
By Eric Barnes
Researchers in Japan and the U.S. are producing promising new head CT images on a work-in-progress 256-slice scanner. A major advantage of so-called area detector scanning is the ability to acquire morphologic and functional images in a single scan, yielding a clutch of new diagnostic possibilities and time-saving exam protocols.
May 27, 2007
2007 05 22 15 57 36 706
PET/MRI system an ISMRM highlight for Siemens
By AuntMinnie.com staff writers
Siemens Medical Solutions of Malvern, PA, has begun demonstrations of a prototype of an imaging system that can perform simultaneous MRI and PET scans.
May 21, 2007
Presurgical fMRI for tumor resection: Are we there yet?
By Shalmali Pal
BERLIN - In theory, functional MRI offers the ultimate noninvasive, presurgical management tool for brain tumor resection. In practice, fMRI techniques have a way to go before they can be as accurate as intraoperative cortical stimulation (ICS), according to Dr. Stefan Sunaert, Ph.D., from the University Hospital of the Catholic University of Leuven in Belgium. Sunaert discussed some of the strengths and weaknesses of fMRI for brain tumor mapping in a talk Sunday at the International Society for Magnetic Resonance in Medicine (ISMRM) meeting.
May 20, 2007
Avid nets financing
By AuntMinnie.com staff writers
Molecular imaging developer Avid Radiopharmaceuticals has closed a $26 million series C financing, co-led by AllianceBernstein and Safeguard Scientifics.
May 9, 2007
Neurognostics gets Wisconsin install
By AuntMinnie.com staff writers
Functional MRI developer Neurognostics has installed its MindState fMRI suite of products at Waukesha Memorial Hospital in Wisconsin.
April 29, 2007
DOTA-NOC PET/CT raises the bar in neuroendocrine imaging
By Jonathan S. Batchelor
Receptors for the naturally occurring neuropeptide somatostatin have been shown to have a high concentration on neuroendocrine tumors. Indium-111-labeled octreotide has long been the preferred agent for imaging somatostatin receptors on neuroendocrine tumors in vivo. But a recent study by German researchers indicates that there may be a new radiotracer of choice for neuroendocrine carcinoma imaging, Ga-68 DOTA-NOC.
April 26, 2007
Small stroke centers ill-equipped for range of presentations
By Eric Barnes
You'll need more than CT and MRI scanners to run a decent stroke center, according to a stroke practice expert from Germany. You'll need staff with expertise in diagnosing and treating the full range of ischemic and hemorrhagic stroke presentations, and enough skilled interventionalists to care for patients who show up at midnight on a holiday.
April 24, 2007
2007 04 24 13 36 01 706
MRI, CT remain front and center in head trauma imaging
By Wayne Forrest
It is estimated that more than 300,000 sports-related concussions occur each year in the U.S., but many concussions are not reported. It often takes an athlete becoming disoriented or losing consciousness before he or she is taken to an emergency room. MRI and CT serve as complementary modalities in head trauma cases such as these.
April 17, 2007
2007 04 17 14 05 09 706
MicroVention enrolls final patient in HELPS trial
By AuntMinnie.com staff writers
Interventional device developer MicroVention of Aliso Viejo, CA, reported that it has enrolled the 500th and final patient in its HydroCoil Endovascular Aneurysm Occlusion and Packing Study (HELPS).
April 4, 2007
MDS Nordion to partner with Avid Radiopharmaceuticals
By AuntMinnie.com staff writers
Radioisotope developer MDS Nordion of Kanata, Ontario, will collaborate with Avid Radiopharmaceuticals to support clinical studies for the Philadelphia company's radiopharmaceuticals designed to diagnose and monitor Alzheimer's disease.
April 3, 2007
CardioVasc acquires Acta Vascular, becomes Nfocus Neuromedical
By AuntMinnie.com staff writers
Interventional device developer CardioVasc of Menlo Park, CA, has completed its acquisition of interventional neuroradiology device manufacturer Acta Vascular of Santa Clara, CA.
April 3, 2007
Previous Page
Page 203 of 238
Next Page